Study of Red Bull™ Sugar-Free Drink for Reduction of Fatigue in Prostate Cancer Patients Receiving LHRH Agonist Therapy
Phase 2
Completed
- Conditions
- Fatigue
- Interventions
- Other: Red Bull™ Sugar-Free Drink
- Registration Number
- NCT01669460
- Lead Sponsor
- University Health Network, Toronto
- Brief Summary
The purpose of this research study is to find out if Red Bull™ Sugar-Free Drink can reduce fatigue in prostate cancer patients receiving LHRH agonist therapy.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Male
- Target Recruitment
- 20
Inclusion Criteria
- Histologically confirmed prostate cancer
- Currently receiving LHRH-agonist therapy for greater than 6 months
- Measurable fatigue, defined as a score of ≥ 2 on the Bruera global fatigue severity scale
- Able to swallow Red Bull™ Sugar-Free Drink
- Life expectancy of at least 1 year
- Able to read and write in English
- Willing to limit consumption of alcohol to one drink per day
Read More
Exclusion Criteria
- Current malignancy or received treatment for a previous malignancy within the last 3 years other than prostate cancer (exceptions are superficial bladder cancer or non-melanoma skin cancer)
- Myocardial infarction within past 6 months
- Any unstable serious co-existing medical condition(s) including but not limited to unstable or poorly controlled coronary artery disease, chronic atrial fibrillation, uncontrolled hypertension, uncontrolled diabetes, severe bleeding diseases or immune disorders
- Evidence of drug or alcohol abuse
- Known hypersensitivity to caffeine
- Known history of liver and kidney insufficiencies
- Known contraindications to Red Bull™ use
Read More
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Red Bull™ Sugar-Free Drink Red Bull™ Sugar-Free Drink Red Bull™ Sugar-Free Drink: two (250mL) cans per day for 28 days
- Primary Outcome Measures
Name Time Method Reduction in overall fatigue as measured by Bruera global fatigue severity scale. Within 4 days after completion of intervention (28 days of Red Bull™)
- Secondary Outcome Measures
Name Time Method Overall improvement in quality of life as measured by the Medical Outcomes Study Short-Form (SF-36) Within 4 days after completion of intervention (28 days of Red Bull™)
Trial Locations
- Locations (1)
University Health Network
🇨🇦Toronto, Ontario, Canada